Buy Erlotero : Erlotinib 150 mg Tablet 30’S Online

Description

Product Overview: Erlotero is a potent medication encapsulating 150 mg of Erlotinib, meticulously formulated by Hetero Drugs Ltd. Erlotero belongs to the class of medications known as kinase inhibitors, specifically targeting epidermal growth factor receptor (EGFR) tyrosine kinase. It is primarily prescribed for the treatment of various cancers, including non-small cell lung cancer and pancreatic cancer, among others.

Key Features:

1. Active Ingredient: Erlotero contains Erlotinib, a targeted therapy medication that interrupts the signals within cancer cells, hindering their growth and spread.
2. Strength: Each tablet of Erlotero comprises 150 mg of Erlotinib, ensuring a precise dosage for effective cancer treatment.
3. Packaging: Erlotero is available in a pack of 30 tablets, providing a convenient supply for continuous therapy as directed by healthcare professionals.
4. Manufactured by Hetero Drugs Ltd.: Erlotero is manufactured with utmost precision and adherence to stringent quality standards by Hetero Drugs Ltd., a trusted pharmaceutical company known for its commitment to excellence in drug manufacturing.

Indications: Erlotero is indicated for the treatment of:

• Non-small cell lung cancer (NSCLC) that has spread to other parts of the body.
• Advanced pancreatic cancer, in combination with another chemotherapy medication, gemcitabine.

Administration: Erlotero tablets are typically taken orally, with or without food, as directed by a healthcare professional. It is essential to follow the prescribed dosage and administration schedule meticulously for optimal therapeutic outcomes.

Storage: Erlotero tablets should be stored at room temperature, away from moisture and heat, in a tightly closed container. Keep Erlotero out of reach of children and pets.

Precautions:

• Prior to initiating Erlotero therapy, patients should inform their healthcare provider about any existing medical conditions, ongoing medications, or allergies.
• Regular monitoring of liver function tests and other relevant parameters may be necessary during Erlotero therapy.
• Patients should avoid grapefruit or grapefruit juice while taking Erlotero, as it may interact with the medication.

Adverse Reactions: Common side effects associated with Erlotero may include rash, diarrhea, nausea, fatigue, loss of appetite, and mouth sores. Patients should promptly report any severe or persistent side effects to their healthcare provider.

Disclaimer: This description provides general information about Erlotero 150 mg Tablet manufactured by Hetero Drugs Ltd. It is not intended to replace professional medical advice or serve as a comprehensive guide. Patients should consult their healthcare provider for personalized guidance regarding the use of Erlotero or any other medication.